| |
| |
|
| Insider
Information: |
Bassler Bonnie L |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
49,456 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,557,918 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,456 |
|
|
| Total
Value |
$2,557,918 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-02-26 |
1,382 |
2019-01-02 |
0 |
Premium* |
|
|
Royalty Pharma Plc |
RPRX |
Director |
2024-03-28 |
47,762 |
2020-06-18 |
0 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
Director |
2021-01-22 |
312 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2024-03-28 |
4 |
A |
$30.23 |
$37,483 |
D/D |
1,240 |
47,762 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-26 |
4 |
S |
$979.25 |
$836,280 |
D/D |
(854) |
1,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-02-26 |
4 |
OE |
$391.92 |
$334,700 |
D/D |
854 |
2,236 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-30 |
4 |
AS |
$959.00 |
$793,093 |
D/D |
(827) |
1,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-30 |
4 |
OE |
$380.95 |
$315,046 |
D/D |
827 |
2,209 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-03 |
4 |
AS |
$914.00 |
$754,964 |
D/D |
(826) |
1,382 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-03 |
4 |
OE |
$380.95 |
$314,665 |
D/D |
826 |
2,208 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135 |
1,382 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-12-29 |
4 |
A |
$27.71 |
$37,493 |
D/D |
1,353 |
46,522 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-12-13 |
4 |
AS |
$870.00 |
$530,700 |
D/D |
(610) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-12-13 |
4 |
OE |
$376.69 |
$229,781 |
D/D |
610 |
1,857 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-09-29 |
4 |
A |
$27.08 |
$37,475 |
D/D |
1,384 |
45,169 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-08-21 |
4 |
AS |
$829.00 |
$707,137 |
D/D |
(853) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-08-21 |
4 |
OE |
$391.92 |
$334,308 |
D/D |
853 |
2,100 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-08-10 |
4 |
AS |
$789.00 |
$673,017 |
D/D |
(853) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-08-10 |
4 |
OE |
$391.92 |
$334,308 |
D/D |
853 |
2,100 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-30 |
4 |
A |
$31.03 |
$37,481 |
D/D |
1,208 |
43,785 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2023-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,747 |
42,577 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-03-24 |
4 |
AS |
$818.00 |
$1,014,320 |
D/D |
(1,240) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-03-24 |
4 |
OE |
$380.95 |
$472,378 |
D/D |
1,240 |
2,487 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-03 |
4 |
AS |
$779.00 |
$795,359 |
D/D |
(1,021) |
1,247 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-03 |
4 |
OE |
$380.95 |
$388,950 |
D/D |
1,021 |
2,268 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
165 |
1,247 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
Director |
– • – |
2022-12-30 |
4 |
A |
$39.76 |
$37,495 |
D/D |
943 |
33,781 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-08 |
4 |
AS |
$779.00 |
$169,822 |
D/D |
(218) |
1,082 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
